BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27802451)

  • 21. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative risk of chronic kidney disease in radical nephrectomy and donor nephrectomy patients: a comparison and analysis of predictive factors.
    Wu FM; Tay MH; Chen Z; Tai BC; Tan LG; Raman L; Tiong HY
    Can J Urol; 2014 Aug; 21(4):7351-7. PubMed ID: 25171278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical predictors of the estimated glomerular filtration rate 1 year after radical nephrectomy in Japanese patients.
    Shimada S; Saito H; Kawasaki Y; Yamashita S; Adachi H; Kakoi N; Namima T; Sato M; Kyan A; Mitsuzuka K; Ito A; Yamaguchi T; Arai Y
    Investig Clin Urol; 2017 Jul; 58(4):228-234. PubMed ID: 28681031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal functional compensation after unilateral radical nephrectomy of renal cell carcinoma].
    Han SC; Huang ZX; Liu HX; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):680-685. PubMed ID: 34393228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
    Takagi T; Kondo T; Iizuka J; Kobayashi H; Hashimoto Y; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2011 Jun; 18(6):472-6. PubMed ID: 21481013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.
    Jeon HG; Gong IH; Hwang JH; Choi DK; Lee SR; Park DS
    BJU Int; 2012 May; 109(10):1468-73. PubMed ID: 21883863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of metabolic syndrome on renal function after radical nephrectomy in patients with renal cell carcinoma.
    Zhang Y; Wu T; Xie J; Yan L; Guo X; Xu W; Wang L
    Int Urol Nephrol; 2021 Oct; 53(10):2127-2135. PubMed ID: 33459957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma.
    Schmid M; Abd-El-Barr AE; Gandaglia G; Sood A; Olugbade K; Ruhotina N; Sammon JD; Varda B; Chang SL; Kibel AS; Chun FK; Menon M; Fisch M; Trinh QD
    Urol Oncol; 2014 Nov; 32(8):1259-66. PubMed ID: 25129142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
    Mason R; Kapoor A; Liu Z; Saarela O; Tanguay S; Jewett M; Finelli A; Lacombe L; Kawakami J; Moore R; Morash C; Black P; Rendon RA
    Urol Oncol; 2016 Nov; 34(11):486.e1-486.e7. PubMed ID: 27344410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Renal Volume: A Surrogate Measure for Radical Nephrectomy-Induced Chronic Kidney Disease.
    Wu FM; Tay MH; Tai BC; Chen Z; Tan L; Goh BY; Raman L; Tiong HY
    J Endourol; 2015 Dec; 29(12):1406-11. PubMed ID: 26204258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma.
    Olivero A; Basso L; Barabino E; Milintenda P; Testino N; Chierigo F; Dell'oglio P; Neumaier CE; Suardi N; Terrone C
    Minerva Urol Nephrol; 2021 Dec; 73(6):789-795. PubMed ID: 33769015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive models for chronic kidney disease after radical or partial nephrectomy in renal cell cancer using early postoperative serum creatinine levels.
    Chae D; Kim NY; Kim KJ; Park K; Oh C; Kim SY
    J Transl Med; 2021 Jul; 19(1):307. PubMed ID: 34271916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma.
    Nguyen MV; Walia A; Saidian A; Puri D; Meagher MF; Hakimi K; Tanaka H; Patil D; Yasuda Y; Saito K; Dhanji S; Cerrato C; Narasimhan R; Perry J; Master V; Fujii Y; Derweesh IH
    BJU Int; 2023 Feb; 131(2):219-226. PubMed ID: 35876044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
    Patel HD; Pierorazio PM; Johnson MH; Sharma R; Iyoha E; Allaf ME; Bass EB; Sozio SM
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1057-1069. PubMed ID: 28483780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients.
    Jang HA; Kim JW; Byun SS; Hong SH; Kim YJ; Park YH; Yang KS; Cho S; Cheon J; Kang SH
    Cancer Res Treat; 2016 Apr; 48(2):612-20. PubMed ID: 26044158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.